Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Validation Study Evaluating the Use of 3H-Cholesterol Bound to Albumin as a Method to Assess Reverse Cholesterol Transport in Subjects With Monogenic Diseases Affecting HDL Metabolism

NCT01782027 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT01782027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01782027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Validation Study Evaluating the Use of 3H-Cholesterol Bound to Albumin as a Method to Assess Reverse Cholesterol Transport in Subjects With Monogenic Diseases Affecting HDL Metabolism
Lead sponsor
University of Pennsylvania
Phase
Not applicable
Overall status
Terminated
Start date
October 31, 2012
Completion date
September 4, 2024
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholesterol, hdl, cholesteryl ester transfer protein (cetp) deficiency, lcat deficiency, lipid metabolism, inborn errors, tangier disease